CCR1 can activate the AKT-ESR1 to promote hepatocellular carcinoma cell proliferation and migration 46 and enhances prostate cancer cell invasive via activating ERK1/2 and Rac signaling 14. This evidence concerns the gene MAPK3 and prostate carcinoma.